Safety and Efficacy of Pre-defined, Fixed Dose of Gonal-f Pen Based on Subject Baseline Characteristics in Subjects Undergoing in Vitro Fertilization (IVF)
Clinical trial NCT00249834 · COMPLETED
Trial details
- NCT number
- NCT00249834
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-22
- Primary completion
- 2006-01-16
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.